Casi pharmaceuticals reports development relating to its disputes with juventas

Beijing , july 19, 2024 /prnewswire/ -- casi pharmaceuticals, inc. (nasdaq: casi), a cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported that it has furnished a current report on form 6-k to disclose material development relating to its dispute with juventas. for details, please visit below link: https://www.sec.gov/archives/edgar/data/1962738/000110465924080958/tm2419826d1_6k.htm about casi pharmaceuticals casi pharmaceuticals, inc. is a biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in china, the united states, and throughout the world.
CASI Ratings Summary
CASI Quant Ranking